301 related articles for article (PubMed ID: 24120370)
1. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ
Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
Gouveia-Figueira S; Karlsson J; Deplano A; Hashemian S; Svensson M; Fredriksson Sundbom M; Congiu C; Onnis V; Fowler CJ
PLoS One; 2015; 10(9):e0139212. PubMed ID: 26406890
[TBL] [Abstract][Full Text] [Related]
3. The fatty acid amide hydrolase and cyclooxygenase-inhibitory properties of novel amide derivatives of carprofen.
Deplano A; Karlsson J; Fowler CJ; Onnis V
Bioorg Chem; 2020 Aug; 101():104034. PubMed ID: 32599361
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and
Deplano A; Karlsson J; Moraca F; Svensson M; Cristiano C; Morgillo CM; Fowler CJ; Russo R; Catalanotti B; Onnis V
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):940-953. PubMed ID: 33896320
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
[TBL] [Abstract][Full Text] [Related]
6. Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen.
Deplano A; Karlsson J; Svensson M; Moraca F; Catalanotti B; Fowler CJ; Onnis V
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):815-823. PubMed ID: 32200655
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of endocannabinoid metabolism by the metabolites of ibuprofen and flurbiprofen.
Karlsson J; Fowler CJ
PLoS One; 2014; 9(7):e103589. PubMed ID: 25061885
[TBL] [Abstract][Full Text] [Related]
9. Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH.
Holt S; Fowler CJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):237-44. PubMed ID: 12644895
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.
Onnis V; Congiu C; Björklund E; Hempel F; Söderström E; Fowler CJ
J Med Chem; 2010 Mar; 53(5):2286-98. PubMed ID: 20143779
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
Vandevoorde S; Fowler CJ
Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
[TBL] [Abstract][Full Text] [Related]
12. Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner.
Fowler CJ; Holt S; Tiger G
J Enzyme Inhib Med Chem; 2003 Feb; 18(1):55-8. PubMed ID: 12751821
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.
Fowler CJ; Björklund E; Lichtman AH; Naidu PS; Congiu C; Onnis V
J Enzyme Inhib Med Chem; 2013 Feb; 28(1):172-82. PubMed ID: 22225576
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen.
Fowler CJ; Janson U; Johnson RM; Wahlström G; Stenström A; Norström K; Tiger G
Arch Biochem Biophys; 1999 Feb; 362(2):191-6. PubMed ID: 9989926
[TBL] [Abstract][Full Text] [Related]
15. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
Rockwell CE; Kaminski NE
J Pharmacol Exp Ther; 2004 Nov; 311(2):683-90. PubMed ID: 15284281
[TBL] [Abstract][Full Text] [Related]
16. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
[TBL] [Abstract][Full Text] [Related]
17. N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase.
Tsuboi K; Hilligsmann C; Vandevoorde S; Lambert DM; Ueda N
Biochem J; 2004 Apr; 379(Pt 1):99-106. PubMed ID: 14686878
[TBL] [Abstract][Full Text] [Related]
18. Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage.
Sasso O; Migliore M; Habrant D; Armirotti A; Albani C; Summa M; Moreno-Sanz G; Scarpelli R; Piomelli D
FASEB J; 2015 Jun; 29(6):2616-27. PubMed ID: 25757568
[TBL] [Abstract][Full Text] [Related]
19. Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen.
Holt S; Nilsson J; Omeir R; Tiger G; Fowler CJ
Br J Pharmacol; 2001 Jun; 133(4):513-20. PubMed ID: 11399668
[TBL] [Abstract][Full Text] [Related]
20. Dual cyclooxygenase-fatty acid amide hydrolase inhibitor exploits novel binding interactions in the cyclooxygenase active site.
Goodman MC; Xu S; Rouzer CA; Banerjee S; Ghebreselasie K; Migliore M; Piomelli D; Marnett LJ
J Biol Chem; 2018 Mar; 293(9):3028-3038. PubMed ID: 29326169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
